<unk>  is indicated for the prevention of strokes and when combined with aspirin, for people with a new coronary stent to prevent closure. Stroke<unk>  is considered a second-line option for the prevention of thrombotic strokes among patients who have previously had a stroke or TIA. Studies have shown that it is superior to aspirin in the prevention of death or future strokes. However, it also has more frequent and serious side effects compared to aspirin, so it is reserved for those patients that cannot take aspirin. Heart disease When a patient needs to have a stent placed in one of the vessels around their heart, it is important that that stent stay open to keep blood flowing to the heart. Therefore, patients with stents must take medications after the procedure to help maintain that blood flow.<unk> , taken together with aspirin, is FDA approved for this purpose, and in studies it has been shown to work better than aspirin alone or aspirin with an anticoagulant. However,<unk> ’s serious side effects make it less useful than its cousin, clopidogrel. Current recommendations no longer recommend<unk> ’s use.
Ticlopidine
Prokarin
Rivaroxaban
Palladin
Eptifibatide
Apixaban
Ticagrelor
Heparin